75N93018C00025

IGF:OT::IGF - ADVANCED DEVELOPMENT AND CLINICAL EVALUATION OF A SYNTHETIC INTRANASAL ENTAMOEBA HISTOLYTICA VACCINE CONTAINING ADJUVANT.

National Institutes of Health · United States

This tender closed on Monday, August 31, 2026. Browse open opportunities

View Source

Time Left to Bid

Closed

ClosedHealthcare & MedicalFederal

Basic information

Reference number: 75N93018C00025
Issuing organization: National Institutes of Health · Find award history →
Government level: Federal
Solicitation type: Healthcare & Medical
Title: IGF:OT::IGF - ADVANCED DEVELOPMENT AND CLINICAL EVALUATION OF A SYNTHETIC INTRANASAL ENTAMOEBA HISTOLYTICA VACCINE CONTAINING ADJUVANT.
Source: USASpending (Federal)
Source ID: usa-75N93018C00025

Details

Location: United States

Description

IGF:OT::IGF - ADVANCED DEVELOPMENT AND CLINICAL EVALUATION OF A SYNTHETIC INTRANASAL ENTAMOEBA HISTOLYTICA VACCINE CONTAINING ADJUVANT. Awarded to: ACCESS TO ADVANCED HEALTH INSTITUTE Agency: Department of Health and Human Services Sub-agency: National Institutes of Health Award type: DEFINITIVE CONTRACT

Dates

Publication: 2018/09/21 12:00:00 AM UTC
Closing date: 2026/08/31 12:00:00 AM UTC

Estimated value

$11.3M USD

Classification

Normalized category

Healthcare & Medical

Source: USASpending (Federal)

Last updated 2026-05-25, 2:30:54 p.m.

Data refreshed every 2 hours